Abstract
It is estimated that viruses play a role in 30% to 80% of asthma exacerbations. Thus, virus vaccination in patients with asthma could play an important role in preventing asthma exacerbations and other complications. Influenza is the only agent for which a routine vaccine is currently available. This article discusses whether influenza vaccination in patients with asthma, based on the available evidence, is justified. Cost-effectiveness of (influenza) vaccination for patients with asthma is questionable. For the other major viruses involved, the present state of affairs is described. Although progress is being made, a vaccine may be available in the near future only for respiratory syncytial virus (RSV). Meanwhile, clinicians and patients should aim for an optimal treatment with the currently available asthma medication.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Huurre TM, Aro HM, Jaakkola JJ: Incidence and prevalence of asthma and allergic rhinitis: a cohort study of Finnish adolescents. J Asthma 2004, 41:311–317.
Johnston NW, Sears MR: Asthma exacerbations. 1: epidemiology. Thorax 2006, 61:722–728.
Minor TE, Dick EC, DeMeo AN, et al.: Viruses as precipitants of asthmatic attacks in children. JAMA 1974, 227:292–298.
Johnston SL, Pattemore PK, Sanderson G, et al.: Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995, 310:1225–1229.
Rawlinson WD, Waliuzzaman Z, Carter IW, et al.: Asthma exacerbations in children associated with rhinovirus but not human metapneum ovirus infections. J Infect Dis 2003, 187:1314–1318.
Bueving HJ, van der Wouden JC, Raat H, et al.: Influenza vaccination in asthmatic children: effects on quality of life and symptoms. Eur Respir J 2004, 24:925–931.
Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307:982–986.
Atmar RL, Guy E, Guntupalli KK, et al.: Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998, 158:2453–2459.
Tan WC: Viruses in asthm a exacerbations. Curr Opin Pulm Med 2005, 11:21–26.
Johnston SL, Pattemore PK, Sanderson G, et al.: The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996, 154(3 Pt 1):654–660.
Izurieta HS, Thompson WW, Kramarz P, et al.: Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342:232–239.
Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR: The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000, 137:856–864.
Dales RE, Schweitzer I, Toogood JH, et al.: Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J 1996, 9:72–77.
Teichtahl H, Buckmaster N, Pertnikovs E: The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997, 112:591–596.
El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB: Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis 2000, 31:96–100.
Tan WC, Xiang X, Qiu D, et al.: Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003, 115:272–277.
Iwane MK, Edwards KM, Szilagyi PG, et al.: Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113:1758–1764.
McKean M, Ducharme F: Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000: CD001107.
Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH: Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003:CD002308.
Rowe BH, Spooner C, Ducharme FM, et al.: Early emergency department treatment of acute asthma a with systemic corticosteroids. Cochrane Database Syst Rev 2001:CD002178.
Weinberger M: Treatment strategies for viral respiratory infection-induced asthma. J Pediatr 2003, 142(suppl 2): S34–S38.
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases: The Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002. http://www.niaid.nih.gov/dmid/vaccines/jordan20
Hayden FG: Rhinovirus and the lower respiratory tract. Rev Med Virol 2004, 14:17–31.
Blomqvist S: Epidemiology of human in rhinoviruses [PhD thesis]. Helsinki, Finland: University of Helsinki; 2004.
Falsey AR, Hennessey PA, Formica MA, et al.: Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005, 352:1749–1759.
Weinberger M: Clinical patterns and natural history of asthma. J Pediatr 2003, 142(suppl 2):S15–S19.
Durbin AP, Karron RA: Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines. Clin Infect Dis 2003, 37:1668–1677.
van Essen GA, Palache AM, Forleo E, Fedson DS: Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003, 21:1780–1785.
Greenberg SB: Respiratory viral infections in adults. Curr Opin Pulm Med 2002, 8:201–208.
World Health Organization: WHO 2003: Influenza Factsheet. http://www.who.int/mediacentre/factsheets/2003/fs211/en Accessed July 2006.
Meier CR, Napalkov PN, Wegmuller Y, et al.: Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000, 19:834–842.
Poehling KA, Edwards KM, Weinberg GA, et al.: The underrecognized burden of influenza in young children. N Engl J Med 2006, 355:31–40.
Govaert TM, Thijs CT, Masurel N, et al.: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661–1665.
Bueving HJ, Bernsen RM, de Jongste JC, et al.: Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 2004, 169:488–493.
Heikkinen T, Silvennoinen H, Peltola V, et al.: Burden of influenza in children in the community. J Infect Dis 2004, 190:1369–1373.
Monto AS: Invited Commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy. Am J Epidemiol 2003, 158:312–315.
Bueving HJ, van der Wouden JC, Berger MY, Thomas S: Incidence of influenza and associated illness in children aged 0–19 years: a systematic review. Rev Med Virol 2005, 15:383–391.
Demicheli V, Rivetti D, Deeks J, Jefferson T: Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2004, 3:CD001269.
Jefferson T, Smith S, Demicheli V, et al.: Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005, 365:773–780.
Villari P, Manzoli L, Boccia A: Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 2004, 22:3475–3486.
Smits AJ, Hak E, Stalman WA, et al.: Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 2002, 128:205–211.
Christy C, Aligne CA, Auinger P, et al.: Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004, 89:734–735.
Abadoglu O, Mungan D, Pasaoglu G, et al.: Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. J Asthma 2004, 41:279–283.
Cates CJ, Jefferson TO, Bara AI, Rowe BH: Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2004:CD000364.
Gessner BD: The cost-effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly. Vaccine 2000, 18:1485–1494.
Turner D, Wailoo A, Nicholson K, et al.: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003, 7:iii–iv, xi–xiii, 1–170.
Nichol KL, Nordin J, Mullooly J: Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. Vaccine 2006, 24:1562–1568.
Demicheli V, Jefferson T, Rivetti D, Deeks J: Prevention and early treatment of influenza in healthy adults. Vaccine 2000, 18:957–1030.
Hak E, van Essen GA, Buskens E, et al.: Is immunizing all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. J Epidemiol Community Health 1998, 52:120–125.
Dayan GH, Nguyen VH, Debbag R, et al.: Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001, 19:4204–4213.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Bueving, H.J., van der Wouden, J.C. What is the role of virus vaccination in patients with asthma?. Curr Allergy Asthma Rep 7, 72–76 (2007). https://doi.org/10.1007/s11882-007-0033-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-007-0033-z